Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology
Titel:
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology
Auteur:
Villavicencio, H. Hernández, C. Gómez, A. Cózar, J.M. Rodríguez-Antolín, A. Prieto, L. de Cabo, M. Malet, J.M. Extramiana, J. Mata, J. Arrabal, M. Server, G. Solsona, E. del Valle, J.I. Miguélez, E. Gutiérrez, E. Elizalde, A. Mateos, J. Artiles, J.L. Jiménez-Cidre, M. Nalda, L.M. Cruz, N. Ozonas, M. Caffaratti, J. Esteban, M. Unda, M. Reina, C. Álvarez-Ossorio, J.L. Lledó, E. Angulo, J.C.